A resected case of effective treatment with S-1/gemcitabine and paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases

Japanese Journal of Cancer and Chemotherapy

Volumn 36, Issue 7, 2009, Pages 1191-1194

  Kimura, Hironobu ^a   Fushida, Sachio ^b   Mukawa, Akio ^c  

^a 2 16 76 Owari cho   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c Hokuriku CPL ^*  (Japan)

Author keywords

Paclitaxel; Panceratic cancer; S 1 gemcitabine

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; PACLITAXEL;

ADULT; ADVANCED CANCER; ANOREXIA; ARTICLE; ASCITES; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOPATHOLOGY; DRUG EFFICACY; FEMALE; GASTRECTOMY; HUMAN; LAPAROSCOPY; LIVER METASTASIS; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; PANCREAS CANCER; PANCREAS RESECTION; PERITONEAL BIOPSY; PERITONEUM METASTASIS; TUMOR SEEDING;

EID: 79959843259     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Burris HA 3rd, Moore MJ, Andersen J, et al: Improvements in survival and clicical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403-2413, 1997.
2. Int J Clin Oncol 9 (Suppl II): 15-19, 2004.